Popular Articles

Cougar Biotechnology Presents Positive CB7630 (Abiraterone Acetate) Phase II Data At ASCO Annual Meeting
Cougar Biotechnology, Inc. (NASDAQ:CGRB) announced that results from ongoing Phase II clinical trials of Cougar"s investigational drug CB7630 (abiraterone acetate) were presented at the 2009 ASCO Annual Meeting that is currently taking place in Orlando, Florida. The data were released today in three poster presentations. These presentations are further detailed below:

MicroRNAs Hold Promise For Treating Diseases In Blood Vessels
A newly discovered mechanism controls whether muscle cells in blood vessels hasten the development of both atherosclerosis and Alzheimer"s disease, according to an article published online in the journal Nature.
News of the day
Home Oxygen Patients And Family Members Visit Capitol Hill To Ask Congress To Protect Medicare Home Oxygen Therapy Benefit
Asking members of Congress to support patient-focused reform of the Medicare home oxygen therapy benefit, patients and family members with the National Emphysema/COPD Association (NECA), a national advocacy organization representing patients with chronic obstructive pulmonary disease (COPD) and other lung diseases, descended on Capitol Hill this week. Patients urged members of the U.S. House to support and pass the Medicare Home Oxygen Therapy Act of 2009 (H.R. 3220), which was recently introduced.
Endocrinology

Stopping Harmful Oral Bacteria In Its Path Is Goal For Case Western Reserve Researcher

The best way to keep bacteria from doing any damage is to stop them in their tracks before they can start down their pathological road to destruction. Yiping Han, associate professor at the Case Western Reserve University School of Dental Medicine, aims to understand how to build roadblocks for a common bacterium that"s harmless in a mother"s mouth but can turn deadly when it reaches an unborn child. She has received a five-year, $1.85 million grant from the National Institute of Dental and Craniofacial Research (NIDCR) at the National Institutes of Health to fund the effort. This is Han"s second NIDCR RO1 award. She"s published more than 10 papers from previous research related to the bacterium, Fusobacterium nucleatum, that creates havoc once it leaves the mouth and enters the blood stream. She has discovered an adhesin protein molecule, called FadA, in the genes of F. nucleatum. This adhesin, or binding agent, on the bacteria allows them to connect with receptors on epithelial cells in the mouth and later the endothelial cells of the placenta. In tests, bacteria without FadA had less binding capability compared to those with the adhesin, Han and a team of researchers report on this finding in the July issue of the journal Infection and Immunity. "With this new grant, we will be able to continue a functional analysis of FadA," said Han. Her research group will look not only at the binding agent but the receptors on the host epithelial and endothelial cells that promote the binding of the oral bacteria. "In some way, the receptors on the host cell activate a signal that puts into action a cascade of processes that allow the bacteria to penetrate the epithelial and endothelial linings and then colonize," explains Han. "We want to block the bacteria before it can do any damage," Han says. "It"s an upstream approach to go back to where the whole process begins and stop it from starting its destruction." Once it leaves the mouth, the invasion of the bacteria through the placenta allows the bacteria to multiple rapidly in the immune-free environment that protects the fetus from being rejected by the mother"s body. The rapid bacterial growth causes the placenta to become inflamed. In turn, the inflammation can trigger preterm birth and fetal death. According to Han this research into the mechanisms of bacterial transport not only has potential to prevent preterm and stillborn births, it may have implications in preventing periodontal disease. Periodontal disease has been linked to such health problem as arthritis, diabetes and heart disease. Susan Griffith Case Western Reserve University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):